Meyer Christian, Metzner Andreas, Kirchhof Paulus
Dtsch Med Wochenschr. 2020 Apr;145(8):543-549. doi: 10.1055/a-0969-6352. Epub 2020 Apr 15.
Rhythm control therapy, comprising antiarrhythmic drugs, cardioversion, and AF ablation, is an important component in the management of patients with atrial fibrillation (AF). Catheter ablation for AF, mainly targeting isolation of the pulmonary veins (AF ablation), has markedly improved the effectiveness of rhythm control therapy. Rhythm control improves symptoms and quality of life in patients with symptomatic AF. AF ablation maintains sinus rhythm more effectively than antiarrhythmic drug therapy. Antiarrhythmic drugs remain effective after AF ablation, underpinning the synergistic mechanisms of action of AF ablation and antiarrhythmic drugs. Different lifestyle interventions might additionally improve symptoms and rhythm stability in patients with AF. AF ablation appears to improve left ventricular function in a subset of patients. Summarized, rhythm control therapy in patients with symptomatic AF is safe and improves quality of life, including elderly patients with stroke risk factors. Further studies are needed to determine whether rhythm control therapy reduces AF-related complications while improving patient outcome with regard to prognosis.
节律控制疗法,包括抗心律失常药物、心脏复律和房颤消融,是心房颤动(AF)患者管理的重要组成部分。主要针对肺静脉隔离的房颤导管消融术(房颤消融)显著提高了节律控制疗法的有效性。节律控制可改善有症状房颤患者的症状和生活质量。房颤消融在维持窦性心律方面比抗心律失常药物治疗更有效。抗心律失常药物在房颤消融术后仍然有效,这支持了房颤消融和抗心律失常药物协同作用的机制。不同的生活方式干预可能会进一步改善房颤患者的症状和节律稳定性。房颤消融似乎能改善一部分患者的左心室功能。总之,有症状房颤患者的节律控制疗法是安全的,可改善生活质量,包括有中风危险因素的老年患者。需要进一步研究以确定节律控制疗法在改善患者预后的同时是否能降低房颤相关并发症。